Anti-ARHGEF12 / LARG

0.5mg/ml if reconstituted with 0.2ml sterile DI water. ARHGEF12, also known as leukemia-associated Rho guanine nucleotide exchange factor or LARG, is a member of the RhoGEF family involved in the regulation of Rho GTPases. These small signaling proteins are crucial for controlling a variety of cellular processes, including cytoskeletal dynamics, cell polarity, migration, and transcriptional activity. ARHGEF12 acts as a guanine nucleotide exchange factor that specifically activates RhoA, linking it to G protein-coupled receptor signaling pathways and other upstream stimuli.ARHGEF12 is widely expressed in multiple tissue types and has been implicated in various physiological and pathological conditions, such as embryonic development, wound healing, and cancer progression. Alternative splicing of the ARHGEF12 gene gives rise to several isoforms that may vary in function and cellular localization, making precise detection and characterization essential in research.A high-quality ARHGEF12 antibody is a critical tool for investigating the diverse roles of this protein in cellular signaling and disease. The ARHGEF12 antibody can be used in western blotting to evaluate protein levels, in immunofluorescence to assess subcellular localization, and in immunohistochemistry for tissue-specific expression profiling. NSJ Bioreagents offers an extensively validated ARHGEF12 antibody designed to provide specificity and reproducibility across multiple experimental platforms.